HUSSAIN IQBAL J — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

HUSSAIN IQBAL J has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $3.58M.

Profile

HUSSAIN IQBAL J

Iqbal J Hussain serves as the General Counsel for Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company. He has been involved in various SEC filings related to the company, indicating his active role in corporate governance and compliance.

RoleChief Legal Officer
Notability30/100

Board memberships

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-06-24CNTACentessa Pharmaceuticals plcD — Derivative transaction5.5K—
2026-06-24CNTACentessa Pharmaceuticals plcD — Derivative transaction117.6K—
2026-02-03CNTACentessa Pharmaceuticals plcA — Grant or award20.0K$0.00
2026-02-03CNTACentessa Pharmaceuticals plcA — Grant or award40.0K$0.00
2026-02-03CNTACentessa Pharmaceuticals plcS — Open-market sale39.0K$25.15$980K
2026-02-03CNTACentessa Pharmaceuticals plcF — Tax withholding / forfeiture7.8K$24.57$191K
2026-02-03CNTACentessa Pharmaceuticals plcS — Open-market sale1.0K$25.01$25K
2025-10-15CNTACentessa Pharmaceuticals plcS — Open-market sale6.0K$22.41$134K
2025-10-15CNTACentessa Pharmaceuticals plcM — Option exercise6.0K$5.84$35K
2025-09-15CNTACentessa Pharmaceuticals plcS — Open-market sale6.0K$21.85$131K
2025-09-15CNTACentessa Pharmaceuticals plcM — Option exercise6.0K$5.84$35K
2025-09-09CNTACentessa Pharmaceuticals plcS — Open-market sale20.0K$22.00$440K
2025-09-09CNTACentessa Pharmaceuticals plcM — Option exercise20.0K$5.84$117K
2025-09-09CNTACentessa Pharmaceuticals plcS — Open-market sale20.0K$20.01$400K
2025-09-09CNTACentessa Pharmaceuticals plcM — Option exercise20.0K$5.84$117K
2025-08-15CNTACentessa Pharmaceuticals plcS — Open-market sale6.0K$17.23$103K
2025-08-15CNTACentessa Pharmaceuticals plcM — Option exercise6.0K$5.84$35K
2025-07-15CNTACentessa Pharmaceuticals plcS — Open-market sale6.0K$14.93$90K
2025-07-15CNTACentessa Pharmaceuticals plcM — Option exercise6.0K$5.84$35K
2024-12-31CNTACentessa Pharmaceuticals plcF — Tax withholding / forfeiture7.5K$16.35$123K

Companies — Last 90 Days

Frequently Asked Questions

Who is HUSSAIN IQBAL J?

Iqbal J Hussain serves as the General Counsel for Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company. He has been involved in various SEC filings related to the company, indicating his active role in corporate governance and compliance.…

How many SEC Form 4 filings has HUSSAIN IQBAL J submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has HUSSAIN IQBAL J been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 9 open-market sales ($3.58M) across all tracked filings.

Where can I see all of HUSSAIN IQBAL J's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live HUSSAIN IQBAL J profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.